{
  "id": 16345583,
  "title": "#ESMO26: AstraZeneca eyes Keytruda's Padcev spot; Lilly's ADC takes on Elahere; Nubeqa targets earlier prostate cancer",
  "url": "https://urgent.news/2026/10/24/esmo26-astrazeneca-eyes-keytrudas-padcev-spot-lillys-adc-takes-on",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-24T16:00:12.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/esmo26-astrazeneca-eyes-keytrudas-padcev-spot-lillys-adc-takes-on-elahere-nubeqa-targets-earlier-prostate-cancer/"
  },
  "original_language": "en",
  "account": null,
  "summary": "MADRID — It's been estimated that almost 40,000 delegates will be attending this year's ESMO congress over five days in Madrid. And on Saturday, they have new data to review from AstraZeneca, Eli Lilly and Bayer. ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}